Biogen Idec to Present at the Credit Suisse 2012 Annual Healthcare Conference

Biogen Idec to Present at the Credit Suisse 2012 Annual Healthcare Conference

Biogen IdecKaren Jewell, 781-464-2442Investor Relations

Biogen Idec Inc. (NASDAQ: BIIB) announced today that its presentation at the Credit Suisse 2012 Healthcare Conference will be webcast live on Wednesday, November 14, 2012 at 9:30 a.m. MT, 7:30am ET. To access the live webcast, please visit Biogen Idec’s Investors section at . An archived version of the webcast will be available for 14 days following the presentation.

Through cutting-edge science and medicine, Biogen Idec discovers, develops and delivers to patients worldwide innovative therapies for the treatment of neurodegenerative diseases, hemophilia and autoimmune disorders. Founded in 1978, Biogen Idec is the world’s oldest independent biotechnology company. Patients worldwide benefit from its leading multiple sclerosis therapies, and the company generates more than $5 billion in annual revenues. For product labeling, press releases and additional information about the company, please visit .

Suggested Articles

A TGen-led research team found that increased activity of the gene AEBP1 drives severe liver fibrosis in nonalcoholic steatohepatitis.

Days after announcing its R&D chief was stepping down, Gilead announced it will be buying a few of Novartis’ unwanted early-stage infection assets.

Mallinckrodt is teaming up with Silence Therapeutics to develop an RNAi program aimed at a group of proteins that play a part in promoting inflammation.